Is SHOT or JNJ a better dividend investment in 2026?

SHOT currently yields 510.59% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SHOT offers higher current income.

What is the dividend yield difference between SHOT and JNJ?

SHOT has a forward dividend yield of 510.59% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 507.23 percentage points.

Home › Compare › SHOT vs JNJ

SHOT vs JNJ: Dividend Comparison 2026

SHOT yields 510.59% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SHOT wins by $72235.41M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SHOT

● Live price

510.59%

Share price

$0.39

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$72235.43M

Annual income

$52,145,507,722.62

Full SHOT calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SHOT vs JNJ

📍 SHOT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SHOT	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SHOT + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SHOT pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHOT

Annual income on $10K today (after 15% tax)

$43,400.56/yr

After 10yr DRIP, annual income (after tax)

$44,323,681,564.23/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SHOT beats the other by $44,323,680,860.61/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHOT + JNJ for your $10,000?

SHOT: 50%JNJ: 50%

100% JNJ50/50100% SHOT

Portfolio after 10yr

$36117.72M

Annual income

$26,072,754,275.20/yr

Blended yield

72.19%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SHOT

No analyst data

Altman Z

-5.5

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHOT buys

JNJ buys

No recent congressional trades found for SHOT or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSHOTJNJ

Forward yield	510.59% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$72235.43M ✓	$20.0K
Annual income after 10y	$52,145,507,722.62 ✓	$827.78
Total dividends collected	$70497.78M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SHOT vs JNJ ($10,000, DRIP)

Year	SHOT Portfolio	SHOT Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$61,759	$51,059.48	$10,676	$355.77	+$51.1K → SHOT
2	$360,794	$294,710.97	$11,407	$389.39	+$349.4K → SHOT
3	$1,995,092	$1,609,043.26	$12,198	$426.53	+$1.98M → SHOT
4	$10,450,244	$8,315,495.12	$13,056	$467.62	+$10.44M → SHOT
5	$51,888,634	$40,706,873.26	$13,987	$513.12	+$51.87M → SHOT
6	$244,419,890	$188,899,051.19	$14,998	$563.56	+$244.40M → SHOT
7	$1,093,121,281	$831,591,999.11	$16,098	$619.52	+$1093.11M → SHOT
8	$4,645,468,190	$3,475,828,418.82	$17,295	$681.69	+$4645.45M → SHOT
9	$18,775,628,147	$13,804,977,184.01	$18,599	$750.82	+$18775.61M → SHOT
10	$72,235,429,840	$52,145,507,722.62	$20,022	$827.78	+$72235.41M → SHOT

SHOT vs JNJ: Complete Analysis 2026

SHOT — Stock

Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen. The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.

Full SHOT Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SHOT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHOT vs SCHD SHOT vs JEPI SHOT vs O SHOT vs KO SHOT vs MAIN SHOT vs ABBV SHOT vs MRK SHOT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.